Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Sep;58(6):634-635.
doi: 10.1111/apt.17656.

Editorial: If STRIDE-II is the hammer, then Crohn's disease and ulcerative colitis are not the same nails-Authors' reply

Axel Dignass  1 , Stefan Rath  2 , Thomas Kleindienst  2 , Andreas Stallmach  3
Affiliations
Editorial

Editorial: If STRIDE-II is the hammer, then Crohn's disease and ulcerative colitis are not the same nails-Authors' reply

Axel Dignass et al. Aliment Pharmacol Ther. 2023 Sep.
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Kedia S, Ahuja V. Editorial: if STRIDE-II is the hammer, then Crohn's disease and ulcerative colitis are not the same nails. Aliment Pharmacol Ther. 2023;58:632-633.
    1. Dignass A, Rath S, Kleindienst T, Andreas S. Review article: translating STRIDE II into clinical reality-opportunities and challenges. Aliment Pharmacol Ther. 2023;58:492-502.
    1. Turner D, Ricciuto A, Lewis A, D'Amico F, Dhaliwal J, Griffiths AM, et al. STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology. 2021;160:1570-1583.
    1. Parigi TL, D'Amico F, Abreu MT, Dignass A, Dotan I, Magro F, et al. Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting. Lancet Gastroenterol Hepatol. 2023:S2468-1253(23)00154-1. https://doi.org/10.1016/S2468-1253(23)00154-1
    1. D'Amico F, Fiorino G, Furfaro F, Allocca M, Roda G, Loy L, et al. Patient's profiling for therapeutic management of inflammatory bowel disease: a tailored approach. Expert Rev Gastroenterol Hepatol. 2020;14:765-773.

LinkOut - more resources